FOLH1 and cancer: This first experience of performing PSMA PET/CT in patients with biochemical recurrence ofprostate cancer treated via the SUS revealed at least three important pieces of information.First, the information provided by this imaging method had a significant impact on therapeuticmanagement, as has been observed worldwide(21).